Adagio Medical Holdings (ADGM) Cash from Financing Activities (2023 - 2024)
Adagio Medical Holdings (ADGM) reported Cash from Financing Activities of $5.1 million for Q2 2024, down 47.01% sequentially from $9.6 million in Q1 2024.
Adagio Medical Holdings (ADGM) Cash from Financing Activities (2023 - 2024) Analysis & Trends
Adagio Medical Holdings (ADGM) has 2 years of Cash from Financing Activities data on file, last reported at $5.1 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn | -25.00 Mn |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn | 21.00 Mn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn | -26.93 Mn |
| 10 | Adagio Medical Holdings | 21.36 Mn | 21.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 5.07 Mn |
| Jun 30, 2024 | 5.07 Mn |
| Mar 31, 2024 | 9.57 Mn |
| Mar 31, 2024 | 9.57 Mn |
| Dec 31, 2023 | 6.58 Mn |
| Dec 31, 2023 | 6.58 Mn |